Brief: Jacobio Pharmaceuticals Says Loss For Year Was RMB371.9 Million
22/03/2023 14:29
March 22 (Reuters) - Jacobio Pharmaceuticals Group Co
Ltd 1167.HK :
* LOSS FOR YEAR RMB371.9 MILLION VERSUS LOSS RMB301.2
MILLION
* FY REVENUE RMB95.7 MLN VS RMB152.8 MLN
Source text for Eikon: ID:
Further company coverage: 1167.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jacobio Pharmaceuticals
See all newsBrief: Jacobio Pharmaceuticals Appoints Xiaojie Wang As Vice Chairperson
China's Jacobio Pharmaceuticals H1 revenue jumps on licensing boost
Brief: Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million
Brief: Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million
HK-listed Jacobio Pharmaceuticals climbs on share buyback plan